John Overdeck’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

John Overdeck’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-143,923	Closed	-$3.96M	–	4928
2021 Q2	$3.96M	Buy	+143,923	New	+$2.83M	0.01%	1339
2021 Q1	–	Sell	-113,092	Closed	-$2.08M	–	4387
2020 Q4	$2.08M	Sell	113,092 -137,932	-55%	-$2.47M	0.01%	1468
2020 Q3	$3.42M	Buy	+251,024	New	+$3.87M	0.01%	990
2020 Q1	–	Sell	-14,176	Closed	-$115K	–	4057
2019 Q4	$115K	Buy	+14,176	New	+$131K	﹤0.01%	3512
2019 Q1	–	Sell	-15,679	Closed	-$118K	–	3604
2018 Q4	$118K	Buy	+15,679	New	+$115K	﹤0.01%	2794

John Overdeck's TBIO Position: Q3 2021 in Review

John Overdeck sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 143,923 shares — an estimated $3.96M sold.

John Overdeck first reported a position in TBIO in Q4 2018 and held it in 5 quarters. The position peaked at $3.96M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

John Overdeck reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
John Overdeck sold 143,923 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $3.96M.
John Overdeck first reported a position in Translate Bio, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
John Overdeck's Translate Bio, Inc. Common Stock position peaked at $3.96M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.